Thromb Haemost 1999; 81(01): 1-7
DOI: 10.1055/s-0037-1614407
Review Article
Schattauer GmbH

The Biology of P-Selectin Glycoprotein Ligand-1: Its Role as a Selectin Counterreceptor in Leukocyte-Endothelial and Leukocyte-Platelet Interaction

Authors

  • Jing Yang

    1   From the Center for Hemostasis and Thrombosis Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
  • Barbara C. Furie

    1   From the Center for Hemostasis and Thrombosis Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
  • Bruce Furie

    1   From the Center for Hemostasis and Thrombosis Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
Further Information

Correspondence to:

Dr. J. Yang
Division of Hematology-Oncology
University of Pennsylvania School of Medicine
415 Curie Boulevard, Philadelphia
PA 19104, USA
Phone: +1 6176670620   
Fax: +16179755505

Publication History

Received07 May 1998

Accepted after revision29 September 1998

Publication Date:
08 December 2017 (online)

 

Summary

Cell-cell interactions mediating leukocyte trafficking, thrombogene-sis and inflammation are crucial for the host defense mechanism. The selectin family of integral membrane proteins includes E-selectin, L-selectin and P-selectin. Selectins mediate tethering and rolling of leukocytes to the vessel wall at the site of inflammation. The counter-receptor for P-selectin and possibly the other selectins is P-selectin glycoprotein ligand-1 (PSGL-1). This review focuses on the properties and biology of PSGL-1.


 



Correspondence to:

Dr. J. Yang
Division of Hematology-Oncology
University of Pennsylvania School of Medicine
415 Curie Boulevard, Philadelphia
PA 19104, USA
Phone: +1 6176670620   
Fax: +16179755505